Huiyu Pharmaceuticals (688553.SH): Multiple products receive overseas listing approval.
Huiyu Pharmaceutical (688553.SH) issued an announcement, the company's subsidiary Seacross Pharmac...
Huayu Pharmaceuticals (688553.SH) announced that its subsidiary, Seacross Pharmaceuticals Ltd., has recently received approval from the Pakistan Drug Regulatory Authority, the UK Medicines and Healthcare Products Regulatory Agency, and the North Macedonia Agency of Medicines and Medical Devices to market the company's products Plestazol Injection, Setapeptide Injection, Azathioprine Injection, Zoledronic Acid Concentrate for Infusion, and Zoledronic Acid Injection.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
